Trident Lifeline Ltd
Trident Lifeline's capital structure shows a debt-to-equity ratio of 0.84, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.69, suggesting it can cover its short-term obligations with its current assets. However, the operating cash flow is negative at -102.4 million INR, which may signal short-term liquidity challenges. In terms of profitability, the company's return on equity (ROE) is 18.23%, and its return on assets (ROA) is 7.53%. These figures are above the industry median for ROE and ROA, indicating that Trident Lifeline is generating strong returns relative to its equity and asset base. The company's revenue is distributed across several geographic segments, with a notable presence in India and other international markets. However, the financial data does not provide specific revenue concentration figures for each segment, making it difficult to assess the level of geographic diversification. Trident Lifeline's growth trajectory is not explicitly detailed in the provided data, but the company's operating income and net income figures suggest a stable performance. The outlook for the current fiscal year is not provided, but the company's free cash flow of 48.9 million INR indicates some capacity for reinvestment or shareholder returns. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to meet long-term obligations. The dilution risk is low, and there are no immediate signs of significant equity dilution. Recent events and filings are not detailed in the provided data, so there is no specific information on recent corporate actions or strategic developments. The company's financial statements and disclosures would need to be reviewed for more detailed insights into recent business activities.
Business. Trident Lifeline Limited (TLL) is an India-based medication provider that produces and sells finished doses across multiple geographies, including India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World.
Classification. Trident Lifeline is classified under the Healthcare economic sector, specifically in the Pharmaceuticals & Medical Research business sector and the Pharmaceuticals industry, with a confidence level of 0.92.
- Trident Lifeline has a strong return on equity (18.23%) and return on assets (7.53%), indicating efficient use of capital and assets.
- The company's debt-to-equity ratio of 0.84 suggests a balanced capital structure with moderate leverage.
- The current ratio of 1.69 indicates the company can cover its short-term liabilities with its current assets.
- The negative operating cash flow of -102.4 million INR may signal short-term liquidity challenges.
- The company's liquidity risk is assessed as medium, and its dilution risk is low.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.